欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号LT/H/0220/001
药品名称JELIGO
活性成分
    • linagliptin 5.0 mg
剂型Film-coated tablet
上市许可持有人Egis Pharmaceuticals PLC Keresztúri út 30-38 Budapest H-1106 Hungary
参考成员国 - 产品名称Lithuania (LT)
Jeligo 5 mg plėvele dengtos tabletės
互认成员国 - 产品名称
    • Poland (PL)
      JELIGO
    • Hungary (HU)
    • Czechia (CZ)
      JELIGO
    • Romania (RO)
      JELIGO 5 mg comprimate filmate
    • Slovakia (SK)
许可日期2024/08/22
最近更新日期2024/08/22
药物ATC编码
    • A10BH05 linagliptin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase